19:50 EDT Eterna Therapeutics trading halted, news pending
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ERNA:
- Ernexa Therapeutics files to sell 57.05M shares of common stock for holders
- Ernexa Therapeutics announces 1-for-15 reverse stock split
- Eterna Therapeutics Completes $6M Private Placement
- Eterna Therapeutics Increases Authorized Shares and Amends Bylaws
- Ernexa Therapeutics announces new data to be presented at ASCO meeting 2025